Aurora Cannabis Gains EU Plant Variety Rights for Innovative Cannabis Varieties

Aurora Cannabis Secures EU Community Plant Variety Rights for Two New Cannabis Varieties

In a significant advancement for the cannabis industry, Aurora Cannabis Inc. (NASDAQ: ACB) has secured Community Plant Variety Rights from the EU’s Community Plant Variety Office for two of its proprietary cannabis varieties. This move not only solidifies Aurora’s intellectual property in cannabis genetics but also enhances its status as a leader in the medical cannabis sector.

The varieties that received protection are named Farm Gas™ (SOT20R07-007) and Sourdough™ (ACB21T044). Developed in Canada through Aurora’s state-of-the-art breeding and phenotyping programs, these cultivars are highly regarded for their exceptional qualities, including high potency, appealing aromas, and robust bud structures. They are available across multiple countries, including Germany, Poland, the UK, Canada, and Australia, and have shown strong consumer demand.

Lana Culley, Vice President of Innovation and International Operations, expressed that the recognition from the EU underscores the remarkable cannabis genetics work being conducted at Aurora’s leading research and development facility. She emphasized that this achievement fortifies Aurora's portfolio while ensuring that their unique varieties can consistently reach patients and consumers on a global scale. The exclusive rights allow Aurora control over the commercial production and sale of these varieties in all 27 EU member states, vastly expanding their market potential.

The acquisition of these rights represents a strategic step for Aurora, as it reinforces their contemporary breeding program, designed to develop cannabis genetics that set new benchmarks in cultivation practices. The market demand for high-quality, differentiated cannabis products drives Aurora to focus on innovation continually, which, in turn, helps maintain its leadership position in the rapidly evolving medical cannabis industry.

This proactive approach to cannabis genetics is accompanied by a robust framework for scientific research and development, sustaining the quality and consistency of the products they offer. Aurora’s diversified product portfolio caters to both medical and recreational cannabis markets, reflecting their commitment to improving the quality of life for consumers and patients around the world.

Moreover, Aurora Cannabis is firm in its assertion that despite the competitive landscape of the cannabis market in Europe, the protection of these varieties enhances their competitive edge significantly. As the market for cannabis continues to expand, Aurora’s commitment to sustain its growth trajectory through continual innovation and safeguarding its intellectual property positions them favorably within the industry.

In conclusion, Aurora Cannabis's recent success in securing these Community Plant Variety Rights not only reflects its dedication to cannabis genetics but also acts as a catalyst for further advancements in the global cannabis landscape. With a clear vision for the future, Aurora aims to remain at the forefront of the revolution in cannabis cultivation and distribution. Echoing the company's mission, "Opening the World to Cannabis™,” there’s a firm belief that the future holds promising developments for this pioneering organization.

Stay tuned for further updates as Aurora Cannabis continues to innovate and expand its operations in the medical and consumer cannabis sectors globally.